SAN FRANCISCO HEALTH PLAN MEDI-CAL FORMULARY Updates

SAN FRANCISCO HEALTH PLAN MEDI-CAL FORMULARY Updates

SAN FRANCISCO HEALTH PLAN MEDI-CAL FORMULARY Updates May, 2021 Effective Date Brand Name Generic Name Type of Change Previous Value New Value 05/14/2021 sodium fluoride fluoride (sodium) ADD TO FORMULARY Tier 1 BRAND-NAME DRUGS are CAPITALIZED. Generic drugs are lower-case italics. PAGE 1 UPDATED 10/2021 SAN FRANCISCO HEALTH PLAN MEDI-CAL FORMULARY Updates July, 2021 Effective Date Brand Name Generic Name Type of Change Previous Value New Value 07/01/2021 BOOSTRIX diphtheria,pertussis(acellular CHANGE UM: QUANTITY 0.5 / DAY 1 fill (0.5 ml) per TDAP,BOOSTRI ),tetanus vaccine lifetime X 07/01/2021 BOOSTRIX diphtheria,pertussis(acellular CHANGE UM: QUANTITY 0.5 / DAY 1 fill (0.5 ml) per TDAP,BOOSTRI ),tetanus vaccine lifetime X 07/01/2021 MENACTRA meningococcalvaccine CHANGE UM: QUANTITY 0.5 / DAY 1 fill (0.5 ml) per a,c,y,w-135,diphtheria toxoid lifetime conj/pf 07/01/2021 ADACEL TDAP diphtheria,pertussis(acellular CHANGE UM: QUANTITY 0.5 / DAY 1 fill (0.5 ml) per ),tetanus vaccine/pf lifetime 07/01/2021 BEXSERO meningococcal group b CHANGE UM: QUANTITY 0.5 / DAY 1 fill (0.5 ml) per vaccine, 4-component lifetime 07/01/2021 DECAVAC,TENI tetanus and diphtheria CHANGE UM: QUANTITY 0.5 / DAY 1 fill (0.5 ml) per VAC toxoids, adsorbed, adult/pf lifetime 07/01/2021 PREVNAR 13 pneumococcal 13-valent CHANGE UM: QUANTITY 0.5 / DAY 1 fill (0.5 ml) per conjugate vaccine lifetime (diphtheria crm)/pf 07/01/2021 TRUMENBA neisseria meningitidis group CHANGE UM: QUANTITY 0.5 / DAY 1 fill (0.5 ml) per b, lipidated fhbp lifetime recombinant 07/01/2021 TENIVAC,TETAN tetanus and diphtheria CHANGE UM: QUANTITY 0.5 / DAY 1 fill (0.5 ml) per US-DIPHTERIA- toxoids, adsorbed, adult/pf lifetime DECAVAC 07/01/2021 ADACEL TDAP diphtheria,pertussis(acellular CHANGE UM: QUANTITY 0.5 / DAY 1 fill (0.5 ml) per ),tetanus vaccine/pf lifetime 07/01/2021 TRUMENBA neisseria meningitidis group REMOVE UM: QUANTITY 1 fill (0.5 ml) per b, lipidated fhbp lifetime recombinant BRAND-NAME DRUGS are CAPITALIZED. Generic drugs are lower-case italics. PAGE 2 UPDATED 10/2021 SAN FRANCISCO HEALTH PLAN MEDI-CAL FORMULARY Updates Effective Date Brand Name Generic Name Type of Change Previous Value New Value 07/01/2021 ESTRING estradiol CHANGE UM: QUANTITY 1 / 30 DAYS 1 / 90 days 07/01/2021 M-M-R II measles, mumps, and REMOVE UM: QUANTITY 1 / DAY VACCINE rubella vaccine live/pf,measles,mumps&rub ella vaccine live/pf 07/01/2021 ACTHIB,HIBERI haemophilus b conjugate REMOVE UM: QUANTITY X vaccine(tetanus toxoid conjugate)/pf 07/01/2021 M-M-R II measles, mumps, and ADD UM: QUANTITY max 2 fills per VACCINE rubella vaccine lifetime live/pf,measles,mumps&rub ella vaccine live/pf 07/01/2021 ACTHIB,HIBERI haemophilus b conjugate ADD UM: QUANTITY max 2 fills per X vaccine(tetanus toxoid lifetime conjugate)/pf 07/01/2021 ACTHIB,HIBERI haemophilus b conjugate REMOVE UM: Limit 3 fills per X vaccine(tetanus toxoid QUANTITYCUSTOM lifetime conjugate)/pf 07/01/2021 M-M-R II measles, mumps, and REMOVE UM: Limit 2 fills per VACCINE rubella vaccine QUANTITYCUSTOM lifetime live/pf,measles,mumps&rub ella vaccine live/pf 07/01/2021 PNEUMOVAX 23 pneumococcal 23-valent REMOVE UM: Limit 2 fills per polysaccharide QUANTITYCUSTOM lifetime vaccine,pneumococcal 23- val p-sac vac 07/01/2021 PNEUMOVAX 23 pneumococcal 23-valent CHANGE UM: QUANTITY 1 / DAY max 2 fills per polysaccharide lifetime vaccine,pneumococcal 23- val p-sac vac 07/01/2021 ACTHIB,HIBERI haemophilus b conjugate CHANGE UM: QUANTITY max 2 fills per max 3 fills per X vaccine(tetanus toxoid lifetime lifetime conjugate)/pf BRAND-NAME DRUGS are CAPITALIZED. Generic drugs are lower-case italics. PAGE 3 UPDATED 10/2021 SAN FRANCISCO HEALTH PLAN MEDI-CAL FORMULARY Updates Effective Date Brand Name Generic Name Type of Change Previous Value New Value 07/01/2021 moban,molindon molindone hcl REMOVE FROM Non-Formulary e hcl FORMULARY 07/01/2021 moban,molindon molindone hcl ADD UM: NTWK CARVE OUT: e hcl FFS MEDI-CAL 07/01/2021 NUPLAZID pimavanserin tartrate REMOVE FROM Non-Formulary FORMULARY 07/01/2021 NUPLAZID pimavanserin tartrate ADD UM: NTWK CARVE OUT: FFS MEDI-CAL 07/01/2021 NUPLAZID pimavanserin tartrate ADD UM: COV Excluded 07/01/2021 moban,molindon molindone hcl ADD UM: COV Excluded e hcl 07/01/2021 VONVENDI von willebrand factor REMOVE FROM Non-Formulary (recombinant) FORMULARY 07/01/2021 VONVENDI von willebrand factor ADD UM: NTWK CARVE OUT: (recombinant) FFS MEDI-CAL 07/01/2021 VONVENDI von willebrand factor ADD UM: COV Excluded (recombinant) 07/01/2021 KCENTRA,BEBU human prothrombin complex REMOVE FROM Non-Formulary LIN VH concentrate (pcc), 4- FORMULARY IMMUNO,BEBUL factor,factor ix complex, IN,PROFILNINE prothrombin complex conc. SD,PROFILNINE (pcc) comb. 6,factor ix complex, prothrombin cplx conc(pcc) no.6, 3- factor,factor ix complex, prothrombin complex conc. (pcc) comb. 4,factor ix complex, prothrombin cplx conc(pcc) no.4, 3-factor BRAND-NAME DRUGS are CAPITALIZED. Generic drugs are lower-case italics. PAGE 4 UPDATED 10/2021 SAN FRANCISCO HEALTH PLAN MEDI-CAL FORMULARY Updates Effective Date Brand Name Generic Name Type of Change Previous Value New Value 07/01/2021 KCENTRA,BEBU human prothrombin complex CHANGE UM: NTWK CARVE OUT: LIN VH concentrate (pcc), 4- FFS MEDI-CAL IMMUNO,BEBUL factor,factor ix complex, IN,PROFILNINE prothrombin complex conc. SD,PROFILNINE (pcc) comb. 6,factor ix complex, prothrombin cplx conc(pcc) no.6, 3- factor,factor ix complex, prothrombin complex conc. (pcc) comb. 4,factor ix complex, prothrombin cplx conc(pcc) no.4, 3-factor 07/01/2021 KCENTRA,BEBU human prothrombin complex CHANGE UM: COV Excluded LIN VH concentrate (pcc), 4- IMMUNO,BEBUL factor,factor ix complex, IN,PROFILNINE prothrombin complex conc. SD,PROFILNINE (pcc) comb. 6,factor ix complex, prothrombin cplx conc(pcc) no.6, 3- factor,factor ix complex, prothrombin complex conc. (pcc) comb. 4,factor ix complex, prothrombin cplx conc(pcc) no.4, 3-factor 07/01/2021 suprax,cefixime cefixime CHANGE UM: AGE Up to 12 yrs old 07/01/2021 cefdinir,omnicef cefdinir CHANGE UM: AGE At least 13 yrs Up to 12 yrs old old 07/01/2021 cefpodoxime cefpodoxime proxetil CHANGE UM: AGE At least 13 yrs Up to 12 yrs old proxetil old 07/01/2021 cefprozil,cefzil cefprozil CHANGE UM: AGE At least 13 yrs Up to 12 yrs old old 07/01/2021 tamiflu,oseltamivi oseltamivir phosphate CHANGE UM: AGE Up to 12 yrs old r phosphate 07/01/2021 cefprozil,cefzil cefprozil CHANGE UM: AGE At least 13 yrs Up to 12 yrs old old BRAND-NAME DRUGS are CAPITALIZED. Generic drugs are lower-case italics. PAGE 5 UPDATED 10/2021 SAN FRANCISCO HEALTH PLAN MEDI-CAL FORMULARY Updates Effective Date Brand Name Generic Name Type of Change Previous Value New Value 07/01/2021 carbamazepine carbamazepine ADD UM: AGE Up to 12 yrs old 07/01/2021 cefdinir,omnicef cefdinir CHANGE UM: AGE At least 13 yrs Up to 12 yrs old old 07/01/2021 multivitamins with pediatric multivitamins no.17 CHANGE UM: AGE Up to 12 yrs old fluoride,multivita with sodium fluoride min with fluoride,multi- vitamin with fluoride 07/01/2021 isoniazid isoniazid CHANGE UM: AGE At least 13 yrs Up to 12 yrs old old 07/01/2021 cefpodoxime cefpodoxime proxetil CHANGE UM: AGE At least 13 yrs Up to 12 yrs old proxetil old 07/01/2021 sucralfate,carafat sucralfate CHANGE UM: AGE Up to 12 yrs old e 07/01/2021 cefaclor,ceclor cefaclor CHANGE UM: AGE At least 13 yrs Up to 12 yrs old old 07/01/2021 cefaclor,ceclor cefaclor CHANGE UM: AGE At least 13 yrs Up to 12 yrs old old 07/01/2021 methylphenidate methylphenidate hcl CHANGE UM: AGE Up to 12 yrs old hcl,methylin 07/01/2021 methylphenidate methylphenidate hcl CHANGE UM: AGE Up to 12 yrs old hcl,methylin 07/01/2021 cefaclor cefaclor CHANGE UM: AGE At least 13 yrs Up to 12 yrs old old 07/01/2021 cleocin clindamycin palmitate hcl CHANGE UM: AGE Up to 12 yrs old pediatric,clindam ycin (pediatric),clinda mycin pediatric 07/01/2021 lexapro,escitalopr escitalopram oxalate CHANGE UM: AGE At least 13 yrs Up to 12 yrs old am oxalate old BRAND-NAME DRUGS are CAPITALIZED. Generic drugs are lower-case italics. PAGE 6 UPDATED 10/2021 SAN FRANCISCO HEALTH PLAN MEDI-CAL FORMULARY Updates Effective Date Brand Name Generic Name Type of Change Previous Value New Value 07/01/2021 tamiflu,oseltamivi oseltamivir phosphate CHANGE UM: AGE Up to 12 yrs old r phosphate 07/01/2021 suprax,cefixime cefixime CHANGE UM: AGE Up to 12 yrs old 07/01/2021 certainty incontinence pad,liner,disp ADD TO FORMULARY Tier 2 07/01/2021 syringe luer-lok syringe, disposable, 50 ml ADD TO FORMULARY Tier 2 07/01/2021 syringe catheter syringe, disposable, 50 ml ADD TO FORMULARY Tier 2 tip 07/01/2021 poise pads incontinence pad,liner,disp ADD TO FORMULARY Tier 2 07/01/2021 personal best peak flow meter ADD TO FORMULARY Tier 2 07/01/2021 insulin syringe syringe with ADD TO FORMULARY Tier 2 needle,insulin,0.3 ml 07/01/2021 NICORETTE nicotine polacrilex ADD TO FORMULARY Tier 2 07/01/2021 veo insulin syringe with ADD TO FORMULARY Tier 2 syringe needle,insulin,0.5 ml 07/01/2021 NIX permethrin ADD TO FORMULARY Tier 2 07/01/2021 veo insulin syringe with ADD TO FORMULARY Tier 2 syringe needle,insulin,0.3 ml 07/01/2021 veo insulin syringe with ADD TO FORMULARY Tier 2 syringe needle,disposable,insulin 1 ml 07/01/2021 VAGISIL benzocaine/resorcinol/aloe ADD TO FORMULARY Tier 2 vera/vitamin e acetate/vit a,d 07/01/2021 ALEVE naproxen sodium ADD TO FORMULARY Tier 2 07/01/2021 AYR SALINE sodium chloride ADD TO FORMULARY Tier 2 07/01/2021 veo insulin syringe with needle,insulin ADD TO FORMULARY Tier 2 syringe 0.3 ml (half unit mark) 07/01/2021 luer-lok syringe- syringe with ADD TO FORMULARY Tier 2 needle needle,disposable, 3 ml BRAND-NAME DRUGS are CAPITALIZED.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    235 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us